CHAL 12 - FTC scrutiny of patent settlements in Hatch-Waxman cases

被引：0

|

作者：

McKithen, Marc ^{[1
]}

机构：

[1] Milbank Tweed Hadley & McCLoy, New York, NY 10005 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

12-CHAL

引用

收藏

页码：953 / 953

页数：1

相关论文

共 16 条

[1] Rational Antitrust Policy and Reverse Payment Settlements in Hatch-Waxman Patent Litigation
Opderbeck, David W.
GEORGETOWN LAW JOURNAL, 2010, 98 (05) : 1303 - 1348
[2] Patent litigation under the Hatch-Waxman Act
Cyr, Shana
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
[3] CHAL 8 - Why Hatch-Waxman is not a model for biosimilars legislation
Watt, Stuart
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 950 - 950
[4] PERSONAL JURISDICTION IN HATCH-WAXMAN CASES
Marusak, Michael
CATHOLIC UNIVERSITY LAW REVIEW, 2016, 66 (01): : 189 - 222
[5] Hatch-Waxman Act - Reverse-Payment Settlements
HARVARD LAW REVIEW, 2013, 127 (01) : 358 - 367
[6] CHAL 36-Overview of pharmaceutical patent-ANDA litigation under the Hatch-Waxman Act
Hasford, Justin J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 901 - 901
[7] The Hatch-Waxman Act during patent prosecution and beyond
Mahn, TG
FOOD AND DRUG LAW JOURNAL, 1999, 54 (02) : 233 - 236
[8] Inducing patent infringement in Hatch-Waxman ANDA litigation
Main, Denise
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[9] Old drugs, new uses: Solving a Hatch-Waxman patent predicament
McPhie, DC
FOOD AND DRUG LAW JOURNAL, 2004, 59 (01) : 155 - 168
[10] BLR archives:: FTC wants Hatch-Waxman changes -: Sees some pharmaceutical companies taking advantage to prolong patent protection
不详
BIOTECHNOLOGY LAW REPORT, 2003, 22 (02) : 118 - 118